Metacrine, Inc.
MTCRDelisted Mar 3, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001634379
Metacrine, Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on Mar 24, 2023; 29 institutions reported holding it in 13F filings for Q4 2022, worth $7.29M in total; no superinvestor held it.
13F holders, Q2 2021
Institutional positions in Metacrine, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- −5 vs. Q1 2021
- Shares held
- 12.5M
- −768.5K (−5.8%) vs. Q1 2021
- Total value
- $47.4M
- −$34.7M (−42.3%) vs. Q1 2021
- New holders
- 8
- 9 more added
- Sold out
- 13
- 15 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MTCR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 5 | $5.30M |
| Q4 2022 | 29 | $7.29M |
| Q3 2022 | 27 | $3.93M |
| Q2 2022 | 25 | $3.06M |
| Q1 2022 | 31 | $3.83M |
| Q4 2021 | 31 | $2.23M |
| Q3 2021 | 35 | $37.9M |
| Q2 2021 | 42 | $47.4M |
| Q1 2021 | 47 | $82.1M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Metacrine, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| New York State Common Retirement Fund | 40 | $0 | 0.00% | −7,060−99.4% | Reduced |
| Citigroup Inc | 84 | $0 | 0.00% | −456−84.4% | Reduced |
| Advisor Group Holdings, Inc. | 15 | $0 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 883 | $3.00K | 0.00% | −312,183−99.7% | Reduced |
| Wells Fargo & Company | 764 | $3.00K | 0.00% | −1,303−63.0% | Reduced |
| Fifth Third Bancorp | 900 | $3.00K | 0.00% | +900 | New |
| UBS Group AG | 1,499 | $6.00K | 0.00% | −876−36.9% | Reduced |
| Tower Research Capital LLC (TRC) | 2,932 | $12.0K | 0.00% | +1,656+129.8% | Added |
| Royal Bank of Canada | 4,376 | $17.0K | 0.00% | −43,681−90.9% | Reduced |
| State Street Corp | 10,605 | $40.0K | 0.00% | −72,025−87.2% | Reduced |
| Edge Wealth Management LLC | 10,600 | $40.0K | 0.01% | +10,300+3,433.3% | Added |
| Walleye Capital LLC | 11,787 | $45.0K | 0.00% | +11,787 | New |
| Northern Trust Corp | 12,231 | $46.0K | 0.00% | −59,577−83.0% | Reduced |
| Wedbush Securities Inc | 12,700 | $48.0K | 0.00% | +12,700 | New |
| Citadel Advisors LLC | 12,710 | $48.0K | 0.00% | +12,710 | New |
| M&T Bank Corp | 13,275 | $50.0K | 0.00% | 00.0% | Unchanged |
| Jacobs Levy Equity Management, Inc | 14,284 | $54.0K | 0.00% | −1,072−7.0% | Reduced |
| Morgan Stanley | 14,699 | $56.0K | 0.00% | +8,862+151.8% | Added |
| Cim Investment Mangement Inc | 19,054 | $72.0K | 0.02% | 00.0% | Unchanged |
| Virtu Financial LLC | 19,671 | $75.0K | 0.01% | +19,671 | New |
| Goldman Sachs Group Inc | 25,303 | $96.0K | 0.00% | +14,694+138.5% | Added |
| Geode Capital Management, LLC | 28,254 | $107.0K | 0.00% | −30,448−51.9% | Reduced |
| Ergoteles LLC | 29,900 | $114.0K | 0.00% | +29,900 | New |
| Bank of America Corp | 34,772 | $132.0K | 0.00% | +10,200+41.5% | Added |
| Two Sigma Advisers, LP | 49,400 | $188.0K | 0.00% | +38,500+353.2% | Added |
| Parametric Portfolio Associates LLC | 55,753 | $212.0K | 0.00% | −38,487−40.8% | Reduced |
| Two Sigma Investments, LP | 64,823 | $246.0K | 0.00% | +64,823 | New |
| New York Life Investments Alternatives | 67,322 | $256.0K | 0.17% | +43,883+187.2% | Added |
| Bridgeway Capital Management, LLC | 79,600 | $302.0K | 0.01% | −55,000−40.9% | Reduced |
| Renaissance Technologies LLC | 79,900 | $304.0K | 0.00% | +79,900 | New |
| BlackRock Inc. | 115,124 | $438.0K | 0.00% | −214,242−65.0% | Reduced |
| Vivo Capital, LLC | 146,426 | $556.0K | 0.02% | 00.0% | Unchanged |
| Millennium Management LLC | 261,420 | $993.0K | 0.00% | −25,527−8.9% | Reduced |
| Deerfield Management Company, L.P. (Series C) | 277,469 | $1.05M | 0.02% | 00.0% | Unchanged |
| FMR LLC | 312,500 | $1.19M | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 408,080 | $1.55M | 0.00% | +160,809+65.0% | Added |
| Prosight Management, LP | 869,082 | $3.30M | 2.09% | +564,597+185.4% | Added |
| Artal Group S.A. | 924,898 | $3.52M | 0.08% | 00.0% | Unchanged |
| ArrowMark Colorado Holdings LLC | 1,046,141 | $3.98M | 0.03% | −13,701−1.3% | Reduced |
| Franklin Resources Inc | 1,309,057 | $4.97M | 0.00% | 00.0% | Unchanged |
| venBio Partners LLC | 3,059,123 | $11.6M | 1.37% | 00.0% | Unchanged |
| NEA Management Company, LLC | 3,062,977 | $11.6M | 0.15% | 00.0% | Unchanged |
| VR Adviser, LLC | 0 | $0 | 0.00% | −680,000−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −179,782−100.0% | Sold out |
| EcoR1 Capital, LLC | 0 | $0 | 0.00% | −62,207−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −13,800−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −11,090−100.0% | Sold out |
| Nuveen Asset Management, LLC | 0 | $0 | 0.00% | −10,906−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −9,999−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −4,242−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −3,853−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −1,600−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −527−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −555−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −233−100.0% | Sold out |